Our studies
Every study includes no-cost study-related care and compensation for your time. Screening is free and never a commitment.
Enrolling now
Mild-to-Moderate Asthma Study
A short study for people whose asthma is generally managed but still present, testing an investigational inhaled treatment.
- Ages
- 12+
- Length
- ~1–2 months
- Compensation
- Up to $1,550 + travel
Moderate-to-Severe Asthma Study
For adults whose asthma still flares up despite daily controller medication. A year of close monitoring and no-cost study care.
- Ages
- 18–75
- Length
- ~12 months
- Compensation
- Up to $3,800
Starting soon
Sign up now and our team will call you before enrollment opens — interest-list patients are screened first.
Moderate-to-Severe COPD Study
A 52-week study of an investigational treatment for adults with moderate-to-severe COPD. Joining the interest list now gets you screened first.
- Ages
- 40–75
- Length
- ~12 months
- Compensation
- Compensated
COPD with Type 2 Inflammation Study
An upcoming study of an investigational add-on treatment for COPD with a specific type of airway inflammation, identified by a simple blood test.
- Ages
- Adults 40+
- Length
- 12–24 months
- Compensation
- Compensated
Chronic Rhinosinusitis with Nasal Polyps Study
An upcoming Phase 3 study for adults with long-term nasal congestion, polyps, and sinus pressure that keeps coming back.
- Ages
- 18+
- Length
- ~12 months
- Compensation
- Compensated